Results 61 to 70 of about 7,007 (181)

Comparative Analysis of Clinical Efficacy of High-Intensity Focused Ultrasound Ablation and Radiofrequency Ablation in Patients with Benign Breast Tumors

open access: yesTechnology in Cancer Research & Treatment
Introduction: This study compared the efficacy, complications, and related indicators of High-Intensity Focused Ultrasound Ablation (HIFU) and Radiofrequency Ablation (RFA) for treating benign breast tumors, aiming to provide effective evidence-based ...
Zhiyong Liu MD   +2 more
doaj   +1 more source

Immediate intraoperative detrusor muscle status at primary transurethral resection of bladder tumour: a prospective, blinded, paired cohort, feasibility study using fluorescence confocal microscopy (IB1‐LaserComplete study)

open access: yesBJU International, Volume 138, Issue 4, Page 705-713, October 2026.
Objectives To evaluate ex vivo fluorescence confocal microscopy (FCM) for immediate detrusor muscle (DM) assessment during primary transurethral resection of bladder tumour (TURBT). Patients and Methods This prospective, blinded, paired‐cohort feasibility study enrolled consecutive patients undergoing primary TURBT for suspected non‐muscle‐invasive ...
Martin J. Connor   +20 more
wiley   +1 more source

HIFU: therapeutische Ultraschallanwendung

open access: yesSwiss Medical Forum ‒ Schweizerisches Medizin-Forum, 2018
Ultraschallwellen konnen in gebundelter und hochintensiver Form zu therapeutischen Zwecken eingesetzt werden.
Aurélien Dupré, David Melodelima
openaire   +1 more source

The effect of ultrasound-guided high-intensity focused ultrasound treatment for cesarean scar pregnancy on ovarian reserve

open access: yesInternational Journal of Hyperthermia, 2021
Objective The aim of this study was to evaluate changes in anti-Müllerian hormone (AMH) levels after ultrasound-guided high-intensity focused ultrasound (USgHIFU) treatment of cesarean scar pregnancy (CSP).
Wenping Wang   +5 more
doaj   +1 more source

Histological characterization of HIFU lesions

open access: yesInternational Journal of Hyperthermia
Background: High intensity focused ultrasound (HIFU) can destroy tissue by thermal ablation which may be accompanied by acoustic cavitation and/or tissue water boiling, but the biological and histological effects of these treatments have not been fully documented. Here, detailed histological analysis over time using well characterized HIFU exposures in
Ian Rivens   +3 more
openaire   +3 more sources

Development of temperature controller-integrated portable HIFU driver for thermal coagulation

open access: yesBioMedical Engineering OnLine, 2019
Background Temperature monitoring during high-intensity focused ultrasound (HIFU) therapy on tissue is essential to regulate the degree of thermal coagulation and to achieve the desired treatment outcomes eventually.
Suhyun Park   +3 more
doaj   +1 more source

Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results

open access: yesInternational Journal of Hyperthermia, 2021
Objective To investigate the clinical effect of high intensity focused ultrasound (HIFU) ablation combined with gonadotropin-releasing hormone agonist (GnRH-a) and levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of adenomyosis ...
Yan Peng   +5 more
doaj   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

open access: yesBMEMat, Volume 4, Issue 3, September 2026.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao   +4 more
wiley   +1 more source

HIFU for Palliative Treatment of Pancreatic Cancer

open access: yes, 2016
Pancreatic cancer is one of the deadliest malignancies, with only a 6 % 5-year survival rate and over 50 % of patients being diagnosed at the advanced stage. Current therapies are ineffective, and the treatment of patients with advanced disease is palliative.
Tatiana D, Khokhlova, Joo Ha, Hwang
openaire   +3 more sources

Recent Advancements in Drug Delivery Across the Blood–Brain Barrier in Amyotrophic Lateral Sclerosis (ALS)

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
Progressive BBB/BSCB dysfunction is increasingly recognized as both a pathological feature and a therapeutic barrier in ALS. Novel delivery technologies and barrier‐restoration strategies may enhance CNS drug exposure, improve the efficacy of disease‐modifying therapies, and advance ALS treatment. ABSTRACT Background Amyotrophic lateral sclerosis (ALS)
Nitesh Sanghai   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy